Using near-infrared spectroscopy to detect subcranial hematoma
A Clinical Prospective Observational Study of Near Infrared Spectroscopy to Detect Subcranial Hematoma
This study is testing if a new tool using near-infrared light can help doctors find blood clots in the brain more accurately in patients who already have a confirmed diagnosis.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 20 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | RenJi Hospital Academic / other |
| Locations | 1 site (Shanghai, Shanghai Municipality) |
| Trial ID | NCT06404645 on ClinicalTrials.gov |
What this trial studies
This clinical trial is a prospective observational study that aims to evaluate the reliability and accuracy of near-infrared spectroscopy (NIRS) in detecting subcranial hematomas. Participants who meet the entry criteria will undergo NIRS detection alongside cranial CT scans to collect data on hematoma thickness and NIRS readings. The study focuses on patients with unilateral subcranial hemorrhage confirmed by CT imaging, providing insights into the effectiveness of NIRS as a diagnostic tool.
Who should consider this trial
Good fit: Ideal candidates for this study are adults over 18 years old with unilateral subcranial hemorrhage confirmed by cranial CT.
Not a fit: Patients with bilateral subcranial hemorrhage or those with specific cranial CT findings such as pneumoperitoneum or skull fractures may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve the accuracy of diagnosing subcranial hematomas, leading to better patient outcomes.
How similar studies have performed: While the use of near-infrared spectroscopy in this context is relatively novel, similar studies have shown promise in other applications of NIRS for detecting various medical conditions.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age above 18 years old 2. Unilateral subcranial hemorrhage confirmed by cranial CT Exclusion Criteria: 1. Bilateral subcranial hemorrhage 2. Intracranial pneumoperitoneum in the location of the hemorrhage on cranial CT 3. Obvious skull fracture in the location of hemorrhage on cranial CT
Where this trial is running
Shanghai, Shanghai Municipality
- Brain Injury Center, Renji Hospital, School of Medicine, Shanghai Jiao Tong University — Shanghai, Shanghai Municipality, China (Recruiting)
Study contacts
- Study coordinator: Ru Gong
- Email: gongru1987@126.com
- Phone: 13512193229
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.